[1] In phase 3 trials, orforglipron produced 12.4% weight loss (27.3 lbs) at 72 weeks less than injectable tirzepatide (20%) but comparable to oral semaglutide
Rafael Acevedo, president/general manager of Dairy Yogurt, Protein Shakes, and Kids Nutrition at Colorado-based Danone U.S., notes overall growth of the yogurt category reflects a broader shift in how consumers are approaching food and health
The approval is supported by two randomized, double-blind, placebo-controlled Phase III trials that enrolled a total 1,220 patients with alopecia areata who had at least 50% scalp hair loss
Side by Side: The Three Oral GLP-1 Pills All three are once-daily pills, so whichever you take, the make-or-break factor is the same: taking it every day without fail
Thats how it supports both fat loss and muscle gain
Action and Therapeutic Potential of Oxyntomodulin